Rocket Pharma FANCA gene therapy (investigational)

FANCA gene therapy · Rocket Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Rocket Pharma FANCA gene therapy (investigational), covering 2025-12-22 to 2025-12-22. Get the full timeline:

Most recent: Clinical Trial Update: Gene Therapy for Fanconi Anemia, Complementation Group A [Phase 2]

See pricing